Chen, William C. http://orcid.org/0000-0001-8924-5853
Choudhury, Abrar http://orcid.org/0000-0001-8312-2457
Youngblood, Mark W. http://orcid.org/0000-0002-1044-8015
Polley, Mei-Yin C.
Lucas, Calixto-Hope G. http://orcid.org/0000-0002-8347-9592
Mirchia, Kanish
Maas, Sybren L. N.
Suwala, Abigail K.
Won, Minhee
Bayley, James C.
Harmanci, Akdes S.
Harmanci, Arif O.
Klisch, Tiemo J. http://orcid.org/0000-0001-8182-384X
Nguyen, Minh P.
Vasudevan, Harish N.
McCortney, Kathleen
Yu, Theresa J.
Bhave, Varun
Lam, Tai-Chung
Pu, Jenny Kan-Suen
Li, Lai-Fung
Leung, Gilberto Ka-Kit http://orcid.org/0000-0003-3147-3057
Chan, Jason W.
Perlow, Haley K.
Palmer, Joshua D. http://orcid.org/0000-0003-3311-0129
Haberler, Christine
Berghoff, Anna S. http://orcid.org/0000-0001-9379-6797
Preusser, Matthias http://orcid.org/0000-0003-3541-2315
Nicolaides, Theodore P.
Mawrin, Christian
Agnihotri, Sameer
Resnick, Adam
Rood, Brian R.
Chew, Jessica
Young, Jacob S.
Boreta, Lauren
Braunstein, Steve E.
Schulte, Jessica
Butowski, Nicholas
Santagata, Sandro http://orcid.org/0000-0002-7528-9668
Spetzler, David
Bush, Nancy Ann Oberheim
Villanueva-Meyer, Javier E.
Chandler, James P.
Solomon, David A. http://orcid.org/0000-0003-4571-7999
Rogers, C. Leland
Pugh, Stephanie L.
Mehta, Minesh P.
Sneed, Penny K.
Berger, Mitchel S.
Horbinski, Craig M. http://orcid.org/0000-0001-8340-9992
McDermott, Michael W.
Perry, Arie http://orcid.org/0000-0002-8300-7261
Bi, Wenya Linda
Patel, Akash J.
Sahm, Felix http://orcid.org/0000-0001-5441-1962
Magill, Stephen T. http://orcid.org/0000-0002-5257-7835
Raleigh, David R. http://orcid.org/0000-0001-9299-8864
Article History
Received: 7 March 2023
Accepted: 11 September 2023
First Online: 9 November 2023
Competing interests
: M.P. has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer, Bristol Myers Squibb, Novartis, Gerson Lehrman Group (GLG), CMC Contrast, GlaxoSmithKline, Mundipharma, Roche, BMJ Journals, MedMedia, Astra Zeneca, AbbVie, Lilly, Medahead, Daiichi Sankyo, Sanofi, Merck Sharp & Dome, Tocagen, Adastra, and Gan & Lee Pharmaceuticals. W.C.C. and D.R.R. are the inventors on patent PCT/US 21/70288 describing the use of targeted gene expression profiling to predict meningioma outcomes and radiotherapy responses. The remaining authors declare no competing interests.